Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Cave

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|November 1, 2008
Selective targeting of NADPH oxidase for cardiovascular protectionAlison Cave
The Lancet. Neurology|May 17, 2024
The prescription of valproate: risk of harmAlison Cave
BMJ (Clinical Research Ed.)|May 13, 2026
Proactive drug safety surveillance should be at the heart of the new Health Data Research ServiceAlison Cave, Anthony Harnden
Clinical Pharmacology and Therapeutics|April 11, 2019
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for EuropeAlison Cave, Xavier Kurz, Peter Arlett
BMJ Open|June 16, 2018
EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-makingKelly Plueschke, Patricia McGettigan, Alexandra Pacurariu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 3, 2005
NADPH oxidase-derived reactive oxygen species in cardiac pathophysiologyAlison Cave, David Grieve, Sofian Johar, et al.
Clinical Pharmacology and Therapeutics|December 18, 2019
Big Data - How to Realize the PromiseAlison Cave, Nikolai C Brun, Fergus Sweeney, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a 'Study-A-Thon'Helen P Booth, John Connelly, Daniel Dedman, et al.
Drug Safety|September 3, 2025
Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory PerspectiveJenny Wong, Katherine Donegan, Kendal Harrison, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|November 1, 2008
Selective targeting of NADPH oxidase for cardiovascular protectionAlison Cave
The Lancet. Neurology|May 17, 2024
The prescription of valproate: risk of harmAlison Cave
BMJ (Clinical Research Ed.)|May 13, 2026
Proactive drug safety surveillance should be at the heart of the new Health Data Research ServiceAlison Cave, Anthony Harnden
Clinical Pharmacology and Therapeutics|April 11, 2019
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for EuropeAlison Cave, Xavier Kurz, Peter Arlett
BMJ Open|June 16, 2018
EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-makingKelly Plueschke, Patricia McGettigan, Alexandra Pacurariu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 3, 2005
NADPH oxidase-derived reactive oxygen species in cardiac pathophysiologyAlison Cave, David Grieve, Sofian Johar, et al.
Clinical Pharmacology and Therapeutics|December 18, 2019
Big Data - How to Realize the PromiseAlison Cave, Nikolai C Brun, Fergus Sweeney, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a 'Study-A-Thon'Helen P Booth, John Connelly, Daniel Dedman, et al.
Drug Safety|September 3, 2025
Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory PerspectiveJenny Wong, Katherine Donegan, Kendal Harrison, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Pageof 2